Greenleaf Trust’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $300K | Sell |
6,235
-886
| -12% | -$41.3K | ﹤0.01% | 653 |
|
|
2025
Q4 | $345K | Sell |
7,121
-372
| -5% | -$18.4K | ﹤0.01% | 599 |
|
|
2025
Q3 | $354K | Sell |
7,493
-1,149
| -13% | -$55.5K | ﹤0.01% | 585 |
|
|
2025
Q2 | $417K | Sell |
8,642
-2,032
| -19% | -$104K | ﹤0.01% | 537 |
|
|
2025
Q1 | $592K | Buy |
10,674
+1,082
| +11% | +$58.6K | 0.01% | 454 |
|
|
2024
Q4 | $463K | Sell |
9,592
-4,222
| -31% | -$215K | ﹤0.01% | 524 |
|
|
2024
Q3 | $796K | Buy |
13,814
+1,025
| +8% | +$55.3K | 0.01% | 393 |
|
|
2024
Q2 | $621K | Buy |
12,789
+4,922
| +63% | +$237K | 0.01% | 421 |
|
|
2024
Q1 | $382K | Sell |
7,867
-269
| -3% | -$13.1K | ﹤0.01% | 539 |
|
|
2023
Q4 | $405K | Sell |
8,136
-10,451
| -56% | -$511K | ﹤0.01% | 522 |
|
|
2023
Q3 | $997K | Buy |
18,587
+1,090
| +6% | +$58.1K | 0.01% | 274 |
|
|
2023
Q2 | $943K | Buy |
17,497
+46
| +0.3% | +$2.48K | 0.01% | 291 |
|
|
2023
Q1 | $950K | Buy |
17,451
+634
| +4% | +$30.8K | 0.01% | 288 |
|
|
2022
Q4 | $814K | Sell |
16,817
-58
| -0.3% | -$2.55K | 0.01% | 315 |
|
|
2022
Q3 | $642K | Buy |
16,875
+5,643
| +50% | +$251K | 0.01% | 341 |
|
|
2022
Q2 | $562K | Buy |
11,232
+848
| +8% | +$45K | 0.01% | 360 |
|
|
2022
Q1 | $533K | Sell |
10,384
-2,075
| -17% | -$107K | 0.01% | 393 |
|
|
2021
Q4 | $624K | Sell |
12,459
-1,057
| -8% | -$52.3K | 0.01% | 354 |
|
|
2021
Q3 | $652K | Sell |
13,516
-687
| -5% | -$34.9K | 0.01% | 324 |
|
|
2021
Q2 | $748K | Sell |
14,203
-976
| -6% | -$50.9K | 0.01% | 294 |
|
|
2021
Q1 | $751K | Buy |
15,179
+96
| +0.6% | +$4.61K | 0.01% | 267 |
|
|
2020
Q4 | $733K | Sell |
15,083
-295
| -2% | -$14.5K | 0.01% | 245 |
|
|
2020
Q3 | $772K | Buy |
15,378
+26
| +0.2% | +$1.34K | 0.01% | 211 |
|
|
2020
Q2 | $784K | Buy |
15,352
+482
| +3% | +$23.4K | 0.01% | 192 |
|
|
2020
Q1 | $650K | Buy |
14,870
+3,808
| +34% | +$182K | 0.01% | 180 |
|
|
2019
Q4 | $555K | Sell |
11,062
-2,948
| -21% | -$138K | 0.01% | 274 |
|
|
2019
Q3 | $649K | Sell |
14,010
-2,532
| -15% | -$109K | 0.01% | 234 |
|
|
2019
Q2 | $716K | Buy |
16,542
+2,358
| +17% | +$100K | 0.01% | 213 |
|
|
2019
Q1 | $628K | Sell |
14,184
-12,878
| -48% | -$552K | 0.01% | 220 |
|
|
2018
Q4 | $1.18M | Buy |
27,062
+10,858
| +67% | +$479K | 0.02% | 136 |
|
|
2018
Q3 | $724K | Buy |
16,204
+316
| +2% | +$13.5K | 0.01% | 217 |
|
|
2018
Q2 | $636K | Sell |
15,888
-2,506
| -14% | -$98.7K | 0.01% | 226 |
|
|
2018
Q1 | $737K | Buy |
18,394
+3,190
| +21% | +$133K | 0.01% | 183 |
|
|
2017
Q4 | $654K | Sell |
15,204
-5,177
| -25% | -$239K | 0.01% | 203 |
|
|
2017
Q3 | $1.01M | Buy |
20,381
+3,951
| +24% | +$191K | 0.02% | 146 |
|
|
2017
Q2 | $787K | Buy |
16,430
+5,364
| +48% | +$256K | 0.02% | 151 |
|
|
2017
Q1 | $501K | Buy |
11,066
+5,846
| +112% | +$248K | 0.01% | 159 |
|
|
2016
Q4 | $211K | Buy |
+5,220
| New | +$206K | 0.01% | 222 |
|
Other funds holding SNY
MIP
Greenleaf Trust's SNY Position: Q1 2026 in Review
Greenleaf Trust reduced its Sanofi (SNY) stake by 12% in Q1 2026, selling an estimated $41.3K and leaving 6,235 shares worth $300K. The position accounts for ﹤0.01% of the portfolio, ranked #653.
Greenleaf Trust first reported a position in SNY in Q4 2016 and has held it in 38 quarters since. The position peaked at $1.18M in Q4 2018. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.
- Greenleaf Trust held 6,235 shares of Sanofi worth $300K as of Q1 2026.
- Greenleaf Trust sold 886 Sanofi shares in Q1 2026, an estimated $41.3K.
- Sanofi made up ﹤0.01% of Greenleaf Trust's portfolio in Q1 2026, its #653 holding.
- Greenleaf Trust first reported a position in Sanofi in Q4 2016 and has held it in 38 quarters since.
- Greenleaf Trust's Sanofi position peaked at $1.18M in Q4 2018.
- 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.
Based on Greenleaf Trust's 13F filing for Q1 2026, filed 27 Apr 2026.